is victoza a glp-1 drug Victoza: The First Generic Receptor Agonist Telehealth Startups Shift to Liraglutide

Castelli MC, Wong DF, Friedman K, Riley MG

The therapeutic dose for weight loss goes up to 2.4 mg

Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment

They delay gastric emptying, slow intestinal transit, and alter the hormonal signaling that coordinates digestion

Ben attributes this to several factors: Proven effectiveness in clinical trials and real-world use Social media and press coverage showcasing dramatic weight loss stories Advances in drug delivery, including long-acting formulations and oral options Expanding indications beyond diabetes to include obesity treatment Were in a situation where its the right molecule at the right time, Ben notes

Consulting LLC Related insights You might also be interested in these insights.